BMGL NASDAQ
Basel Medical Group Ltd Ordinary Shares
1W: -11.3%
1M: -33.6%
3M: -53.4%
YTD: -52.1%
1Y: -84.2%
$3.28
+0.26 (+8.61%)
Weekly Expected Move ±35.4%
$1
$2
$3
$4
$6
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$4M
-273.1% ▼
Capital Expenditures
$55K
-591.4% ▼
3Y CAGR: -14.8%
Free Cash Flow
-$4M
-275.9% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$1M
+40.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| — Operating Activities — | ||||
| Net Income | $2M | $2M | $2M | -$13M |
| Depreciation & Amort. | $576K | $557K | $529K | $1M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in Working Capital | $81K | $287K | -$5K | -$3M |
| Other Non-Cash Items | -$251K | -$376K | -$419K | $10M |
| Operating Cash Flow | $3M | $3M | $3M | -$4M |
| — Investing Activities — | ||||
| Capital Expenditures | -$88K | -$6K | -$8K | -$55K |
| Acquisitions (Net) | $0 | $0 | $0 | -$11M |
| Investment Purchases | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$88K | -$6K | -$8K | -$11M |
| — Financing Activities — | ||||
| Net Debt Issuance | -$2M | -$3M | -$3M | -$5M |
| Stock Repurchased | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Financing | -$11M | $325 | $1M | $12M |
| Financing Cash Flow | -$13M | -$3M | -$2M | $17M |
| Net Change in Cash | -$10M | -$346K | $734K | $1M |
| Cash End of Period | $2M | $1M | $2M | $3M |
| Free Cash Flow | $3M | $3M | $3M | -$4M |